OKX said Wednesday it will launch perpetual futures contracts tied to private companies including OpenAI, SpaceX, and Anthropic, joining a growing cohort of crypto venues racing to bring pre-IPO price exposure on-chain. The contracts are synthetic — they track the private firms' implied valuations without granting equity ownership or shareholder rights, mirroring a product category that Injective launched last year and Bitget entered in April with a Solana-based SpaceX-linked token issued through Republic. Injective framed the same product as a way to pull the $13 trillion private equity market "directly on-chain."
Why it matters
The category is the clearest signal yet that crypto exchanges are deliberately expanding their addressable market beyond BTC and ETH into the private equity space — a $13T asset class retail traders have historically had no clean way to access. OKX's entry also intensifies competitive pressure on Injective and Bitget in a niche that didn't exist 12 months ago. The structural caveat is identical across every product in the space: these are price-tracking derivatives, not securities. Robinhood learned that distinction the hard way last year when OpenAI publicly distanced itself from OpenAI-linked tokens, warning that any transfer of actual equity would require the company's approval.
Market impact
The contracts give crypto-native traders a new venue to express directional views on the most-watched private names, which can compress the price-discovery gap between secondary private-market quotes and public sentiment. Watch the basis between OKX's perps and the underlying private-market valuations — sustained divergence would be the first sign the synthetic market is pricing something other than the reference equity. The bigger read is regulatory: synthetic private-equity exposure sits in a grey zone that has already drawn public pushback from the companies being tokenized, and the CFTC's posture on whether perps on private firms qualify as derivatives on a "commodity" will set the ceiling for the entire category.
Frequently asked questions
-
Does the OKX OpenAI perpetual future give you actual OpenAI equity?
No. The contract is a synthetic derivative that tracks the private firm's implied valuation; it confers no equity ownership and no shareholder rights. OKX, Injective, and Bitget all market the same structure.
-
Why are crypto exchanges launching perps on private companies?
Exchanges are expanding beyond BTC and ETH into the $13 trillion private equity market, giving retail traders a way to express directional views on pre-IPO names that were previously inaccessible without accredited-investor status.
-
How is OKX's product different from Robinhood's OpenAI tokens?
OKX's perps are synthetic price-tracking derivatives with no underlying equity. Robinhood's tokens were backed by a special purpose vehicle holding equity purchased on the secondary market — a structure OpenAI publicly distanced itself from last year.
-
Which private companies is OKX offering perps on?
OKX named OpenAI, SpaceX, and Anthropic in its Wednesday announcement. Injective's pre-IPO perps cover a similar set including OpenAI, Anthropic, SpaceX, and Perplexity, while Bitget's IPO Prime product launched with a SpaceX-linked token.
-
What's the regulatory risk for synthetic private-equity perps?
The category sits in a grey zone — synthetic perps on private firms are not securities, but regulators could still challenge the structure. The CFTC's posture on whether perps on private companies qualify as derivatives on a commodity will set the ceiling for the entire category.
CoinDesk